Companies › CE

CE 10-K & 10-Q changes, risk factors and insider trading

Celanese Corp · NYSE · Plastic Material, Synth Resin/rubber, Cellulos (No Glass) · CIK 1306830 · All filings on SEC.gov

Everything below is quoted or computed from Celanese Corp's public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

13 / 6risk-factor paragraphs added / removed in latest 10-K
1new risk-factor headings
3Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparing 10-K filed 2026-02-24 (period ending 2025-12-31) with 10-K filed 2025-02-21 (period ending 2024-12-31).

Risk Factors (10-K Item 1A)

13new paragraphs
6removed paragraphs
40reworded paragraphs
11,171 → 11,987words in section

New heading “Our increasing reliance on artificial intelligence ("AI") technologies in our products, services, and operations presents risks that could adversely impact our business, financial condition, and results of operations.”

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text topics: artificial intelligence
“Our increasing reliance on artificial intelligence ("AI") technologies in our products, services, and operations presents risks that could adversely impact our business, financial condition, and results of operations.”
see in full comparison
New text topics: impairment, goodwill
“The goodwill and indefinite-lived intangible asset impairment analyses are sensitive to changes in key assumptions used, such as discount rate, revenue growth rate, tax rate, cash flow projections and terminal value rate. Such key assumptions may be adversely impacted by significant negative industry or economic trends and forecasts, disruptions to our business, inability to effectively integrate acquired businesses, unexpected significant change or planned changes in use of our assets, changes in the structure of our business, divestitures, or further decline to market capitalization. …”
see in full comparison
Removed text topics: impairment, goodwill
“The goodwill and indefinite-lived intangible asset impairment analyses are sensitive to changes in key assumptions used, such as discount rate, revenue growth rate, tax rate, cash flow projections and terminal value rate. Such key assumptions may be adversely impacted by significant negative industry or economic trends and forecasts, disruptions to our business, inability to effectively integrate acquired businesses, unexpected significant change or planned changes in use of our assets, changes in the structure of our business, divestitures, or market capitalization declines. …”
see in full comparison
Reworded topics: downgrade, credit rating, interest rate

Paragraph as it now reads, with added and removed wording marked:

•Exposing us to the risk of increased interest rates as certain of our borrowings are at variable rates of interest or increase their interest rates in the event of credit rating downgrades;
see in full comparison
New text topics: impairment, goodwill
“As of December 31, 2025, the Company has $4.2 billion of goodwill and $1.2 billion of indefinite-lived intangible assets recorded on its balance sheet. We test goodwill and indefinite-lived intangibles for impairment at least annually and more frequently if the Company believes indicators of impairment exist. The valuation models used to determine the fair value of goodwill or indefinite-lived intangible assets are dependent upon various assumptions and reflect management's best estimates.”
see in full comparison
Removed text topics: impairment, goodwill
“At December 31, 2024, the Company has $5.4 billion of goodwill and $1.5 billion of indefinite-lived intangible assets recorded on its balance sheet. We test goodwill and indefinite-lived intangibles for impairment at least annually and more frequently if the Company believes indicators of impairment exist. The valuation models used to determine the fair value of goodwill or indefinite-lived intangible assets are dependent upon various assumptions and reflect management's best estimates.”
see in full comparison
Full comparison: every changed paragraph (59)

Green = added, red = removed. Unchanged paragraphs, 1 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

The following risks could materially and adversely affect our business, financial condition, cash flows and results of operations, and the trading price of our common stock or outstanding senior notes could decline. These risk factors do not identify all risks that we face; our operations could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations. Additionally, some of the factors,disclosures events,in this section reflect our beliefs and contingenciesopinions discussedas belowto mayfactors havethat occurredcould materially and adversely affect us in the past,future. References to past events are provided by way of example only and the disclosures below are not representationsintended to be a complete listing or a representation as to whether or not thesuch factors, events or contingenciesfactors have occurred in the past,past butor aretheir provided because future occurrenceslikelihood of suchoccurring factors,in events,the or contingencies could have a material adverse effect.future. Due to risks and uncertainties, known and unknown, our past financial results may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. Refer also to the other information set forth in this Form 10-K, including in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations and the accompanying consolidated financial statements and notes thereto.

Reworded

We operate globally and have customers in many countries. Our major facilities are primarily located in North America, Europe and Asia, and we hold interests in affiliates that operate in the United States ("U.S."), Germany, China, Japan, South Korea and Saudi Arabia. Our principal customers are similarly global in scope and the prices of our most significant products are typically regional or world marketindex prices. Consequently, our business and financial results are affected, directly and indirectly, by world economic conditions, including demand declines, declines in consumer and business confidence, fluctuating commodity prices and interest rates, cost inflation, instability in credit markets, volatile exchange rates and other challenges such as the changing regulatory environment.

Reworded

Our operations are also subject to global political conditions, which may be subject to heightened uncertainty as a result of changes in governmental administration in the jurisdictions in which we operate and elsewhere.uncertainty. For example, any future changes to laws or regulations, withdrawal or renegotiation of treaties or trade agreements, or the failure to reach agreement over trade agreements,matters, or the imposition of new or increased tariffs, including, but not limited to, anti-dumping and countervailing duties, on our products or raw materials, or the more aggressive prosecution of trade disputes with countries like China, may increase costs or reduce profitability, or adversely affect our ability to operate our business and execute our growth strategy. In addition, it may be more difficult for us to enforce agreements, collect receivables, receive dividends and repatriate earnings through foreign legal systems. In certain foreign jurisdictions our operations are subject to nationalization and expropriation risk and some of our contractual relationships within these jurisdictions are subject to cancellation without full compensation for loss. Furthermore, in certain cases where we benefit from local government subsidies or other undertakings, such benefits are subject to the solvency of local government entities and are subject to termination without meaningful recourse or remedies.

Reworded

We have invested significant resources in China and other Asian countries. This region's growth may continuenot tobe slow,as anticipated, or trade flows could be negatively impacted, and we may fail to realize the anticipated benefits associated with our investment there and, consequently, our financial results may be adversely impacted.

Added

From time to time, we provide guidance regarding our expected financial performance, which may take the foregoing and other factors into account. Correctly identifying key factors affecting business conditions and predicting future events is inherently an uncertain process, and our guidance may not ultimately be accurate. If our guidance varies from actual results, the market value of our common stock could decline significantly.

Reworded

Like many companies, in recent years, we have experienced significant supply disruptions and increased costs of inputs. These trends have impacted, and may in the future impact, our operating costs. We have previously undertaken efforts to offset these costs through pricing actions, alternative supply arrangements, and hedging strategies, however, these have not eliminated all exposure to inflationary pressure. We cannot always successfully pass increased costs to customers, and even where we are successful, increased prices have led to and could lead to reduced demand for our products or could result in competitive disadvantages.

Reworded

•The direct or indirect effect of governmental regulation (including the impact of government regulation relating to duties (e.g., tariffs) or other trade barriers, power usage, climate change or regulation of production and transport of certain chemicals).

Reworded

A disruption in production at one or more of our manufacturing facilities, or those of our suppliers, could have a material adverse effect on our business. Disruptions or interruptions of operations could occur for many reasons, including fire, flood, hurricanes, natural disasters, severe weather, unplanned maintenance or other manufacturing problems, public health crises, disease, geopolitical events, strikes or other labor unrest, transportation interruption, government regulation, political unrest or terrorism, accidents, interruptions in sources of raw materials, cybersecurity incidents, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East), other catastrophic events, or other unforeseen events or delays in construction or operation of facilities. Alternative facilities with sufficient capacity or capabilities may not be available, may cost substantially more or may take a significant time to start production, each of which could negatively affect our business and financial performance.

Reworded

We have experienced disruptions of the type described above in recent years. For example, in 2024, concurrent outages by two of our suppliers of critical raw materials for production of acetic acid and subsequent production of VAM at our U.S. gulf coast sites led to the declaration of force majeure for these products sold in the Western Hemisphere. Additionally, we proactively and temporarily shut down one or more of our Texas production facilities during Winter Storm Uri in February 2021 and Hurricane Laura in August 2020, each of which instances resulted in lost sales and impacted our financial results for the relevant quarter.

Reworded

We may continue to experience difficulties orand delays achieving the intended benefits from acquiring the M&M Business.

Reworded

In November 2022, we completed the acquisition of the Mobility & Materials business ("M&M Business") of DuPont.DuPont de Nemours, Inc. (the "M&M Acquisition"). Since closing, we have actively worked, and continue to actively work, to integrate the M&M Business and its systems into our own and improve the performance of the M&M Business. The benefits of the M&M Acquisition, including the anticipated financial benefits and the synergies and growth opportunities, may not be realized as expected or may not be achieved within the anticipated timeframe, or at all. Since closing we have also worked, and continue to actively work, to integrate the M&M Business and its systems into our own. For example, in February 2024 we incorporated the M&M Business into the new enterprise resource planning ("ERP") system used by the Company. As we work to further integrate technology, information and ERP systems, financial reporting and commercial activities, it is possible that we may encounter unanticipated delays, costs or inefficiencies in connection with our continuing efforts to integrate the M&M Business.

Reworded

If the potential financial and other benefits and synergies of the M&M Business going forward do not materialize in the amounts or on the timing we expect, or if we are not as successful as we plan at aligning our and the M&M Business's practices and operations, then our business, financial performance and operating results could be adversely affected.

Added

As of December 31, 2025, the Company has $4.2 billion of goodwill and $1.2 billion of indefinite-lived intangible assets recorded on its balance sheet. We test goodwill and indefinite-lived intangibles for impairment at least annually and more frequently if the Company believes indicators of impairment exist. The valuation models used to determine the fair value of goodwill or indefinite-lived intangible assets are dependent upon various assumptions and reflect management's best estimates.

Added

The goodwill and indefinite-lived intangible asset impairment analyses are sensitive to changes in key assumptions used, such as discount rate, revenue growth rate, tax rate, cash flow projections and terminal value rate. Such key assumptions may be adversely impacted by significant negative industry or economic trends and forecasts, disruptions to our business, inability to effectively integrate acquired businesses, unexpected significant change or planned changes in use of our assets, changes in the structure of our business, divestitures, or further decline to market capitalization. Changes in market conditions or key assumptions made in future quantitative tests could negatively impact the results of future impairment testing for any of the Company's reporting units and could result in the recognition of an impairment loss. Because of the significance of our goodwill and indefinite-lived intangible assets, any future impairment of these assets could require material noncash impairment losses, which also could be material to our statements of operations.

Added

During the year ended December 31, 2025, we recognized a noncash goodwill impairment loss of $1.1 billion in our Engineered Materials segment. In addition, we recognized noncash impairment losses of $346 million for the year ended December 31, 2025 related to certain trade names, primarily Zytel®, included in the Engineered Materials segment. See Note 9 - Goodwill and Intangible Assets, Net in the accompanying consolidated financial statements for further information.

Added

There can be no assurance that future events or conditions may not result in additional impairment losses in our engineered materials reporting unit or impairment losses to any of our other reporting units' goodwill or to any of our indefinite-lived intangible or long-lived assets.

Reworded

Failure to develop new productsproducts, product applications, and production technologies, or to implement productivity and cost reduction initiatives successfully,technologies may harm our competitive position.

Reworded

Our operating results depend significantly on the development of commercially viable new products, product grades and applications, as well as improving process technologies. If we are unsuccessful in developing new products, applications and improved production processes in the future, including failing to leverage our opportunity pipeline in our Engineered Materials segment, our competitive position and operating results may be negatively affected. However, as we invest in new technology, we face the risk of unanticipated operational or commercialization difficulties, including an inability to obtain necessary permits or governmental approvals, the development of competing technologies, failure of facilities or processes to operate in accordance with specifications or expectations, construction delays, cost overruns, the unavailability of financing, required materials or equipment and various other factors. Likewise, we have undertaken and are continuing to undertake initiatives in all of our business segments to improve productivity and performance and to generate cost savings. These initiatives, which may be limited or offset by, among other things, contractual obligations, may not be completed or beneficial or the estimated cost savings from such activities may not be realized.

Reworded

Our products provide important performance attributes to our customers' products. IfIn the event that one of our products fails to perform in a manner consistent with applicable quality specifications, customers have previously sought and a customer could in the future seek replacement of the product or damages for costs incurred as a result of the product failing to perform as specified. A successful claim or series of claims against us could have a material adverse effect on our reputation, financial condition and results of operations and could result in a loss of one or more key customers.

Reworded

These operating and other risks canhave previously caused and could in the future cause personal injury, property damage, third-party damages and environmental contamination, and may result in the shutdown of affected facilities and the imposition of civil or criminal penalties. The occurrence of any of these events may disrupt production and have a negative effect on the productivity and profitability of a particular manufacturing facility, our operating results and cash flows.

Removed

At December 31, 2024, the Company has $5.4 billion of goodwill and $1.5 billion of indefinite-lived intangible assets recorded on its balance sheet. We test goodwill and indefinite-lived intangibles for impairment at least annually and more frequently if the Company believes indicators of impairment exist. The valuation models used to determine the fair value of goodwill or indefinite-lived intangible assets are dependent upon various assumptions and reflect management's best estimates.

Removed

The goodwill and indefinite-lived intangible asset impairment analyses are sensitive to changes in key assumptions used, such as discount rate, revenue growth rate, tax rate, cash flow projections and terminal value rate. Such key assumptions may be adversely impacted by significant negative industry or economic trends and forecasts, disruptions to our business, inability to effectively integrate acquired businesses, unexpected significant change or planned changes in use of our assets, changes in the structure of our business, divestitures, or market capitalization declines. Changes in market conditions or key assumptions made in future quantitative tests could negatively impact the results of future impairment testing for any of the Company's reporting units and could result in the recognition of an impairment charge. Because of the significance of our goodwill and indefinite-lived intangible assets, any future impairment of these assets could require material noncash impairment losses, which also could be material to our statements of operations.

Removed

During the three months ended December 31, 2024, we recognized a non-cash goodwill impairment loss of $1.5 billion in our Engineered Materials segment. Additionally, we recognized aggregate non-cash impairment losses of $117 million for the year ended December 31, 2024 related to certain trade names, primarily Zytel®, included in the Engineered Materials segment. See Note 9 - Goodwill and Intangible Assets, Net in the accompanying consolidated financial statements for further information.

Removed

There can be no assurance that future events or conditions may not result in additional impairments in our engineered materials reporting unit or impairment to any of our other reporting units' goodwill or to any of our indefinite-lived intangible or long-lived assets.

Reworded

We may incur significant charges or experience other significant risks and uncertainties in the event we close or divest all or part of a manufacturing plant or facility andor engage in other divestitures that introduce significant risks and uncertainties.divestitures.

Reworded

We periodically assess our manufacturing operations in order to manufacture and distribute our products in the most efficient manner. Based on our assessments, we may make capital improvements to modernize certain units, move manufacturing or distribution capabilities from one plant or facility to another plant or facility, discontinue manufacturing or distributing certain products or close or divest all or part of a manufacturing plant or facility. We also have shared services agreements at several of our plants and if such agreements are terminated or revised, we would assess and potentially adjust our manufacturing operations. The intended closure of our facility in Mechelen,Lanaken, Belgium, resulted in charges during fiscal 2024 andBelgium is expected to result in chargescharges, including employee termination costs, of $140 million through fiscal 2028.2027. The closure or divestiture of all or part of a manufacturing plant or facility could result in future charges that could be significant. Additionally,In addition, as part of our deleveraging efforts, we may engage in opportunistic dispositions or monetization of product or business lines or other assets.assets, Divestituressuch as our completed divestiture of the Micromax® business. Such actions involve significant risks and uncertainties that could adversely affect our business, results of operations and financial condition. These include, among others, the inability to find potential buyers on favorable terms, disruption to our business and/or diversion of management attention from other business concerns, loss of key employees, renegotiation or termination of key business relationships, retention of certain liabilities related to the divested business or other assets and indemnification or other post-closing claims. See Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information.

Reworded

We currently participate in a number of joint ventures and may enter into additional joint ventures in the future. Our joint ventures require us to work cooperatively with unaffiliated third parties. Differences in views among joint venture participants may result in delayed decisions or failure to agree on major decisions. Additionally,In addition, our partners may be unable or unwilling to meet their economic or other obligations to the joint ventures, which could negatively impact them. If these risks cause the joint ventures to fail to achieve their desired operating performance, our results of operations could be adversely affected.

Reworded

We have been and will continue to be subject to advanced and persistent threats in the areas of information and operational technology security and fraud. We rely on information and operational technology systems, including tools that utilize artificial intelligence, to conduct our business. We seek to prevent unauthorized access, maintain the confidentiality and the integrity of our information and operational technology systems and strive to detect and investigate any cybersecurity incidents that may occur, however in some cases we might be unaware of a particular incident or its magnitude and effects. We may face increased information technology security, continuity and fraud risks due in part to our business efforts to digitize certain operations at our manufacturing sites to increase efficiencies and to our continued reliance on many employees working remotely part of the time, which may create additional information security vulnerabilities and/or magnify the impact of any disruption in information technology systems. In addition, the rapid evolution and increased adoption of artificial intelligence technologies may intensify our cybersecurity risks. Many tools and resources we use integrate or will integrate some form of artificial intelligence, which has the potential to result in bias, miscalculations, data errors, intellectual property infringement and other unintended consequences. Artificial intelligence technologies may also be used by adversaries to enable new or augment existing attack techniques, tactics and protocols. Additionally,In addition, we may be exposed to unauthorized access or operational interruptions to our information or operational technology systems through undetected vulnerabilities in our service providers' information systems or software. These risks may be heightened as a result of our ongoing efforts to integrate the M&M Business's technology environment with our own. It may take considerable time for us to investigate and evaluate the full impact of incidents, particularly for sophisticated attacks. These factors may inhibit our ability to provide prompt, full, and reliable information about the incident to our customers, partners, regulators, and the public.

Reworded

The declaration, payment, and amount of any dividends, and/or the decision to purchase common stock under our share repurchase programs, are subject to the sole discretion of our Board of Directors and, in the context of our capital allocation strategy, will depend upon many factors, including our financial condition, operating results, cash flows, relevant prospects, our capital requirements and access to capital markets, covenants associated with certain of our debt obligations, legal requirements, and other factors that our Board of Directors may deem relevant, and there can be no assurances that we will continue to pay a dividend or repurchase shares of our common stock in the future. In furtherance of our deleveraging efforts, we have paused our share repurchase program and are in the process of evaluating additional cash generation or conservation opportunities. As part of this process, on November 4, 2024, we announced our intent to reducereduced our quarterly dividend by approximately 95 percent95% beginning in the first quarter of 2025. We plan to continue to evaluate our dividend policy, taking into account our ability to return to a balanced capital allocation strategy. Any further reduction or elimination of our dividends could adversely affect the price of our common stock.

Added

Our increasing reliance on artificial intelligence ("AI") technologies in our products, services, and operations presents risks that could adversely impact our business, financial condition, and results of operations.

Added

We are increasingly incorporating AI capabilities into the development of technologies and our business operations, and into our products and services, including, for example, our Chemille platform. AI technology is complex and rapidly evolving, and may subject us to significant competitive, reputational, cybersecurity, legal, regulatory, operational and other risks. If our products and services incorporating AI fail to operate as anticipated or as well as competing offerings or otherwise do not meet customer needs, our business and reputation may be adversely impacted. Our use of AI may introduce operational vulnerabilities by producing inaccurate outcomes or suggestions. Incorporating AI also gives rise to litigation risk and risk of non-compliance and unknown cost of compliance, as AI is an emerging technology for which the legal and regulatory landscape is not fully developed or uniform.

Added

Our efforts to develop and use AI responsibly, may not successfully mitigate all associated risks. Any failure to address concerns relating to the responsible use of AI technology may cause harm to our reputation or financial liability and, as such, may increase our costs to address or mitigate such risks and issues.

Reworded

We are subject to extensive international, national, state, local and other laws and regulations. Failure to comply with these laws, including antitrust, anticorruption and sanctions laws, rules, regulations or court decisions, could expose us to fines, penalties and other costs. Although we have implemented policies, procedures and employee training designed to promote compliance with these laws, rules, regulations and court decisions, there can be no assurance that our employees and business partners and other third parties acting on our behalf will comply with these laws, rules, regulations and court decisions, which could result in fines, penalties and costs and damage to our business reputation. For example, in July 2020 we announced that we had reachedsettled a finalEuropean settlement of $92 million with respect to aCommission competition law investigation byinvolving thecertain Europeanof Commissionour basedsubsidiaries onand three other companies related to certain past ethylene purchases by certain subsidiaries of the Company.purchases. Shell Chemicals Europe, anothercertain groupRepsol entities represented by Stichting Ethylene Claims ("Stichting"), TotalEnergies, OMV, Borealis, LyondellBasell, and more recently, Stichting, on behalf of corporateVersalis claimants, and, most recently, TotalEnergies Petrochemicals & Refining SAentities, have each filed separate claims for damages with the District Court of Amsterdam against four companies, including the Company,Celanese, arising from those activities. BASFPreliminary SEhearings hashave been held in certain of these matters. With respect to the Stichting Repsol claims, a ruling on the initial phase, which phase is related to liability and not monetary damages, could be received in the first quarter of 2026, but we do not expect that such ruling would include a damages award or conclude the matter. BASF, Dow, ExxonMobil, BP, MOL Group and Braskem have filed a similar claimclaims against Celanese in the Court of Munich, Germany, and Dow filed a second claim against Celanese and others in the Court of Dortmund, Germany. In sum, 11 new claims were filed against Celanese and other ethylene purchasers in 2025 and early 2026, and we anticipate that new or existing claimants may assert additional claims or seek additional damages associated with the 2020 European Commission settlement. We expect additional hearings will take place and briefings will be filed in 2026. See Note 19 - Commitments and Contingencies in the accompanying consolidated financial statements for further information.

Reworded

Moreover, changes in laws or regulations, including the more aggressive enforcement of such laws and regulations, such as unexpected changes in regulatory requirements (including trade compliance requirements), or changes in reporting requirements of the U.S., Canadian, Mexican, German, EU or Asian governmental agencies, could increase the cost of doing business in these regions.regions or delay or restrict our collection of accounts receivable. In addition, enforcement of environmental or other governmental policy may result in plant shut downs or significantly decreased production, such as in China on high pollution days. Any of these types of conditions, including the failure to obtain or maintain operating permits for our business, may have an effect on our business and financial results as a whole and may result in volatile current and future prices for our products and raw materials. See Note 19 - Commitments and Contingencies in the accompanying consolidated financial statements for further information.

Reworded

New or revised governmental regulations, independent studies or consumer or societal perceptions relating to the effect of our products on health, safety or the environment may affect demand for our products and the cost of producing our products. In addition, products we produce, including VAM, formaldehyde, polymers derived from formaldehyde and acetaldehyde, may be classified and labeled in a manner that would adversely affect demand for such products. For example, in 2019 the EPA designated formaldehyde as a high-priority substance under the Toxic Substances Control Act ("TSCA") and the substance is currently undergoing a multi-step review process. In December 2024, the EPA issued its final risk evaluation of certain uses of formaldehyde under the TSCA. WeIn anticipateDecember that, consistent with the TSCA,2025, the EPA released an Updated Draft Risk Calculation Memorandum for Formaldehyde for public comment. EPA anticipates that it will develop a draft risk management plan that is expected to be released by early summer 2026 for public comment in approximately 12 months.comment.

Reworded

Greenhouse gas ("GHG") emissions have become the subject of significant international, national, regional, state and local attention. For example, the EPA, SEC, and European Commission have promulgated or proposed extensive rules concerning reporting of GHG emissions. The European Commission has also embarked on the European Green Deal initiative with the goal of making the EU carbon neutral by 2050, including an interim goal of 90% reduction by 2040, which is leading to additional statutory and regulatory requirements. In addition, regulation of greenhouse gas also could occur pursuant to future treaty obligations, statutory or regulatory changes or new climate change legislation intended to reduce or mitigate the effects of GHG emissions. Compliance with such legislation, regulation and accords and the associated potential cost is complicated by the fact that various countries and regions are following different approaches and standards to the regulation of climate change.

Reworded

Physical impacts that could be associated with climate change, such as increased frequency and severity of hurricanesfires, anddroughts, hurricanes, floods and impactother weather events and impacts on sea levels, as well as other catastrophic events, may also impact our facilities and operations and those of our key suppliers. A number of our sites are located in areas that are exposed to weather events and changing sea levels (such as the Texas Gulf Coast) and that have been impacted by hurricanes and other weather events in the past as described elsewhere in these risk factors. To the extent climate change exacerbates these threats, our operations and supply chains could experience increased levels of disruptions and added costs.

Reworded

Additionally,In addition, increased social, legislative and regulatory focus on climate change and other sustainability matters as well as customer demand for responsibly manufactured products could lead to changes in the behavior of our customers or their end-customers, and could result in reduced customer demand for products made from materials that are perceived to be significant contributors to greenhouse gas emissions and global climate change. We may fail to accurately react to these trends and refine our product offerings through innovation, or we may not be able to fully address these concerns through changes in manufacturing methods or use of more sustainable materials and processes, which could result in reduced demand for our products.

Reworded

Our aspirations, goals,aspirations and initiatives related to sustainability, and our public statements and disclosures regarding them, expose us to risks.

Reworded

We have developed and publicized, and expect to continue to establish, goals, targets, aspirations, and other objectives related to sustainability matters. These include a GHG intensity reduction target and other environmental targets. Such statements reflect our current plans at the time they are made, and do not constitute a guarantee that they will be achieved. Our ability to track and meet these goals depends on future innovations and technology and the availability of accurate reporting methods. Our efforts to research, establish, accomplish, and accurately report on these goals, targets, aspirations and objectives could expose us to operational, reputational, financial, legal, and other risks. Our ability to achieve any stated goal, target, or objective is and will be subject to numerous factors and conditions, many of which are outside of our control, such as evolving regulatory or quasi-regulatory sustainability standards, the ability of suppliers to meet our sustainability and other standards, differing requirements and the pace of changes in technology.

Reworded

We may face increased scrutiny from the investment community, other stakeholders, regulators, and the media related to our sustainability activities, including the goals, targets, aspirations and objectives that we announce, and our methodologies and timelines for pursuing them. If our sustainability practices do not meet regulator, investor or other stakeholder expectations and standards, which continue to evolve and may be conflicting, our reputation, ability to attract or retain employees, and attractiveness as an investment, business partner, or as an acquirer could be negatively impacted, or we could become the target of litigation, investigations or other proceedings initiated by government authorities or private actors, which could in turn adversely impact our business and results of operations. Similarly, our failure or perceived failure to pursue or fulfill our goals, targets, aspirations and objectives, to comply with ethical, environmental, or other standards, regulations, or expectations, or to satisfy various reporting standards with respect to these matters, within the timelines that we announce, or at all, could have the same negative impacts, as well as expose us to government enforcement actions and private litigation. Even if we achieve the goals, targets, aspirations and objectives we set, we may not realize all of the benefits expected at the time they were established.

Reworded

For example, the Organization of Economic Cooperation and Development (the "OECD"), which represents a coalition of member countries, is supporting changes to numerous long-standing tax principles through its base erosion and profit shifting initiatives, which focus on a number of issues, including (i) the shifting of profits among affiliated entities located in different tax jurisdictions and (ii) a global minimum tax of at least 15% of adjusted financial statement income, applied on a country-by-country basis, applicable to multinational groups with annual revenue of EUR750 million or more. The adoption of such changes is contingent upon the independent actions of participating countries to enact implementing domestic legislation. Countries where we do business, including several EU member states, have either implemented, or are in the process of implementing, the 15% global minimum tax into domestic legislation. Consistent with a joint statement from the United States and G7 countries that was issued in June 2025, on January 5, 2026, the OECD released a "side-by-side" safe harbor from the global minimum tax rules that, if enacted into local law in the relevant jurisdiction, would establish a new side‑by‑side safe harbor under which U.S.‑parented groups may, for fiscal years starting in 2026, elect to be exempt from certain elements of the global minimum tax, particularly the "income inclusion rule" and the "undertaxed profits rule." The effect of this "side-by-side" safe harbor will ultimately depend on whether, when and how individual jurisdictions implement the "side-by-side" safe harbor into domestic law, and there is significant uncertainty regarding scope, timing and consistency of such implementation.

Reworded

Our tax returns have been under audit for the years 2013 through 2015 by the United States, the Netherlands and Germany. In September 2021, we received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The relevant tax authorities also proposed to apply these adjustments to open tax years through 2019. We were unable to reach an agreement with the relevant tax authorities and therefore these audits continued on a separate jurisdictional basis. InDuring the fourththree quartermonths ofended December 31, 2022, we concluded settlement discussions with the Dutch tax authority, and induring the thirdthree quartermonths ofended September 30, 2024, we concluded settlement discussions with the German tax authority related to the German transfer pricing audit. We engaged in continuing discussions with the tax authority in the United States, and we are currently evaluating all additional potential remedies regarding the ongoing examination.

Reworded

In addition, we are under examination in certain jurisdictions for other matters for various years, including Mexico, Canada, the United StatesStates, China, South Korea and Germany.

Removed

In addition, we rely on our senior management team specifically, therefore our future success depends in part on our ability to retain those members of senior management and to identify and develop talent to succeed senior management. The hiring and retention of key personnel and appropriate senior management succession planning will continue to be important to the successful implementation of our strategies.

Removed

As of December 31, 2024, we had 12,163 employees globally. Approximately 13% of our 4,085 U.S.-based employees are unionized. In addition, a large number of our employees are employed in countries in which employment laws provide greater bargaining or other employment rights than the laws of the U.S. Such employment rights require us to work collaboratively with the legal representatives of the employees to effect any changes to labor agreements. Most of our employees in Europe are represented by workers councils and/or unions that must approve any changes in terms and conditions of employment, including potentially salaries and benefits. They may also impede efforts to restructure our workforce. Although we believe we have a good working relationship with our employees globally and their legal representatives, a strike, work stoppage, or slowdown by our employees, including in connection with renegotiation of labor contracts from time to time, could occur, resulting in a disruption of our operations or higher ongoing labor costs.

Reworded

Our indebtedness and interest expense, could adversely affect us, decrease our business flexibility, diminish our ability to raise additional capital to fund our operations or refinance our existing indebtedness when it matures, adversely affect our credit ratings,ratings (which may in turn increase our interest expense), and limit our ability to react to changes in the economy or the chemicals industry.

Reworded

As of December 31, 2024,2025, our total debt was $12.6 billion. Despite our level of indebtedness, we expect to continue to have the ability to borrow additional debt.debt though there is no guarantee we will be able to borrow on the same terms as our existing indebtedness. There may be circumstances in which required payments of principal and/or interest on our debt could adversely affect our cash flows, our operating results or our ability to return capital to our shareholders. We have allocated, and intend to continue to allocate, capital to repay and reduce our outstanding debt using cash from operations and proceeds from asset sales or dispositions in cases where we are able to do so on favorable terms. Our ability to reduce our level of indebtedness over time in line with our strategic goals depends on a number of factors including our business performance, macroeconomic and industry conditions, commercial and financing market conditions, and other factors described in these risk factors, and our inability to achieve these objectives could delay or alter our deleveraging plan, or could negatively impact the trading prices of our securities or our credit ratings. In furtherance of our deleveraging efforts, we have completed our planned divestiture of the Micromax® business, executed a number of transactions to manage our debt maturity profile, paused our share repurchase program and are in the process of evaluating additional cash generation or conservation opportunities. As part of this process, on November 4, 2024, we announced our intent to reducereduced our quarterly dividend by approximately 95 percent95% beginning in the first quarter of 2025.

Reworded

•Increasing our vulnerability to general economic and industry conditions, including exacerbating the impact of any adverse business effectsconditions that could impact our ability to repay amounts due under or refinance on favorable terms existing senior credit agreements (the "Credit Agreements") or the indentures (the "Indentures") governing our outstanding senior unsecured notes (collectively, the "Senior Notes");

Reworded

•Exposing us to the risk of increased interest rates as certain of our borrowings are at variable rates of interest or increase their interest rates in the event of credit rating downgrades;

Reworded

•Adversely affecting our future credit ratings, which could increase our futureborrowing costs of funding,costs, liquidity and access to capital markets; and

Added

We remain in compliance with the covenants in our material financing arrangements as of December 31, 2025.

Added

Due to scheduled step downs of the required consolidated leverage ratio under our U.S. revolving credit facility (the "U.S. Revolving Credit Facility") taking effect beginning in the first quarter of 2026, we believe we may be unable to comply with the consolidated leverage ratio in its current form within the twelve-month period subsequent to the date of this filing unless we are able to implement sufficient mitigation strategies. Such strategies include, but are not limited to, amending the outstanding U.S. Revolving Credit Facility consistent with prior similar amendments we have obtained over the past several years, obtaining a waiver of the default, replacing the U.S. Revolving Credit Facility with a new revolving credit facility, consummating additional divestiture opportunities, and/or reducing operating costs. Implementation of such strategies may increase our borrowing costs under existing material financing arrangements. If we are not able to implement sufficient mitigating strategies and are therefore not able to comply with the consolidated leverage ratio, the lenders under the U.S. Revolving Credit Facility could elect to terminate the facility. As of the date of this filing, the U.S. Revolving Credit Facility has no outstanding borrowings.

Reworded

We may not be able to generate sufficient cashcash, through normal operations, productivity and cost reduction initiatives, or otherwise, to service our indebtedness and may be forced to take other actions to satisfy obligations under our indebtedness, which may not be successful.

Added

We have undertaken and are continuing to undertake initiatives in all of our business segments to improve productivity and performance and to generate cost savings to support our deleveraging efforts. These initiatives, which may be limited or offset by, among other things, contractual obligations, may not be completed or beneficial or the estimated cost savings from such activities may not be realized.

Reworded

The Credit Agreements, the Indentures and the Receivables Purchase Agreement governing our receivables securitization facility each contain various covenants that limit our ability to engage in specified types of transactions. The Credit Agreements require the maintenance of certain financial ratios and contain other covenants including, but not limited to, restrictions on our and certain of our subsidiaries' ability to incur additional debt; incur liens securing debt; increase dividends, repurchase our Common Stock or make other restricted payments; merge or consolidate with any other person; and sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of the Issuer's assets or the assets of certain subsidiaries. Additionally, the Credit Agreements require the maintenance of certain financial ratios. The Indentures contain covenants including, but not limited to, restrictions on our and certain of our subsidiaries' ability to incur liens securing debt; merge or consolidate with any other person; and sell, assign, transfer, lease, leaseback, convey or otherwise dispose of certain or all or substantially all of the Issuer's assets or the assets of certain subsidiaries.

Reworded

Our credit ratings are an assessment by rating agencies of our ability to pay our debts when due. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our securities. These credit ratings may not reflect the potential impact of risks relating to our securities. Agency ratings are not a recommendation to buy, sell or hold any security, and may be revised or withdrawn at any time by the issuing organization. Each agency's rating should be evaluated independently of any other agency's rating. InWe Novemberhave 2024,in S&Pthe Globalpast Ratingsbeen downgraded our long-term credit rating from BBB-subject to BB+,ratings with a stable outlookdowngrades, and in December 2024 Fitch Ratings affirmed our long-term credit rating of BBB- but revised our rating outlook to negative from stable. On February 12, 2025 Moody's Ratings downgraded our long-term and short-term credit ratings from Baa3 to Ba1 with a negative outlook. Wewe cannot be assured that we will be able to maintain our current credit ratings, and any additional actual or anticipated negative changes or downgrades in our credit ratings or ratings outlook or watch, including any announcement that our ratings are under review for a downgrade, could further increase our corporate borrowing costs and affect the market value of our securities and may have a negative impact on our liquidity, capital position and access to capital markets.

Added

In addition, we rely on our senior management team specifically, therefore our future success depends in part on our ability to retain those members of senior management and to identify and develop talent to succeed senior management. The hiring and retention of key personnel and appropriate senior management succession planning will continue to be important to the successful implementation of our strategies. To help attract, retain, and motivate qualified employees, we use share-based awards and performance-based cash incentive awards. Sustained declines in our stock price or lower stock price performance relative to our competitors have reduced the retention value of our share-based awards, which can impact the competitiveness of our compensation. To the extent our compensation programs are not viewed as competitive, our ability to attract, retain, and motivate employees can be weakened, which could harm our results of operations.

Added

As of December 31, 2025, we had 11,434 employees globally. Approximately 14% of our 3,763 U.S.-based employees are unionized. In addition, a large number of our employees are employed in countries in which employment laws provide greater bargaining or other employment rights than the laws of the U.S. Such employment rights require us to work collaboratively with the legal representatives of the employees to effect any changes to labor agreements. Most of our employees in Europe are represented by workers councils and/or unions that must approve any changes in terms and conditions of employment, including potentially salaries and benefits. They may also impede efforts to restructure our workforce. Although we believe we have a good working relationship with our employees globally and their legal representatives, a strike, work stoppage, or slowdown by our employees, including in connection with renegotiation of labor contracts from time to time, could occur, resulting in a disruption of our operations or higher ongoing labor costs.

Management's Discussion & Analysis (MD&A) (10-K Item 7)

52new paragraphs
51removed paragraphs
44reworded paragraphs
8,675 → 7,938words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text topics: impairment, restructuring, goodwill, china
“•prior year impacts of a non-deductible goodwill impairment loss and recognition of a valuation allowance against certain local country, non-U.S. tax credit carryforwards due to reduced forecasts of earnings in future periods and capital gains tax arising from an internal integration-related restructuring of our acquired China operations to optimize our debt profile.”
see in full comparison
New text topics: default, liquidity
“Due to scheduled step downs of the required consolidated leverage ratio under the U.S. Revolving Credit Facility taking effect beginning in the first quarter of 2026, we believe we may be unable to comply with the consolidated leverage ratio in its current form within the twelve-month period subsequent to the date of this filing unless we are able to implement sufficient mitigation strategies. Such strategies include, but are not limited to, amending the outstanding U.S. …”
see in full comparison
New text topics: downgrade, credit rating, interest rate
“On November 17, 2025, S&P Global Ratings downgraded our credit rating and on November 25, 2025, Moody's Ratings downgraded our credit rating, which together will have the effect of increasing interest rates for certain senior unsecured notes by an additional 50 basis points, effective on various dates beginning January 15, 2026 through May 15, 2026.”
see in full comparison
Removed text topics: impairment, goodwill
“During the three months ended December 31, 2024, the Company experienced a significant and sustained decrease in the Company's share price. …”
see in full comparison
Removed text topics: impairment, goodwill
“•a decrease in Net earnings, excluding the non-cash impacts of impairment losses, primarily due to the goodwill impairment loss of $1.5 billion in the Engineered Materials segment, (see Note 9 - Goodwill and Intangible Assets, Net in the accompanying consolidated financial statements for further information), deferred income taxes of $1.2 billion and the gain of $515 million recognized on the formation of the Nutrinova joint venture during the year ended December 31, 2023, which did not recur in the current year (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying …”
see in full comparison
Removed text topics: fine, covenant
“We remain in compliance with the covenants in the existing Global Credit Agreements (defined below, and as amended to date) and expect to remain in compliance based on our current expectation of future results of operations and planned cash generation activities. If the actual future results of our operations and cash generation activities differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the existing Global Credit Agreements.”
see in full comparison
Full comparison: every changed paragraph (147)

Green = added, red = removed. Unchanged paragraphs, 8 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Added

•the ability to successfully achieve planned cost reductions;

Added

•our level of indebtedness and our financial condition, each of which could diminish our ability to raise additional capital to fund operations, reduce our business and strategic flexibility, increase our interest expense, limit the success of our deleveraging efforts, and impact changes to our credit ratings, which could increase our interest expense in the event of additional downgrades;

Reworded

•additional impairmentsimpairment of goodwill or intangible assets;

Removed

•risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility;

Reworded

•compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, AI-related vulnerabilities, terrorism or political unrest, public health crises, or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or conflicts in the Middle East) or terrorist incidents or as a result of fire, flood, hurricanes, other severe weather, natural disasters, other catastrophic events or other crises;

Reworded

•changes in applicable tariffs, dutiesduties, treaties and trade agreements, tax rates or legislation throughout the world including, but not limited to, anti-dumping and countervailing duties, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States ("U.S.") and other jurisdictions;

Removed

•our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemical industry, and the success of our deleveraging efforts, as well as any changes to our credit ratings.

Reworded

Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Annual Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of the datesdate hereof.

Reworded

_____________________________ (1)Defined as Operating profit (loss) divided by Net sales.

Removed

•lower pricing, driven by our Acetyl Chain segment due to an environment with greater supply than demand, as well as our Engineered Materials segment due to competitive market dynamics, product mix, and decreased energy surcharges;

Removed

•lower volume in our Engineered Materials segment primarily due to the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information) and reduced demand for elastomers due to weaker automotive demand, partially offset by higher volume, principally for POM in Europe and Asia; and

Removed

•an unfavorable currency impact, primarily resulting from a weaker Chinese Yuan ("CNY") and Japanese Yen ("JPY") relative to the U.S. dollar;

Removed

•higher volume in our Acetyl Chain segment for most of our products, primarily methanol, downstream derivative products, acid, and VAM.

Removed

Operating profit decreased $2.4 billion, or 141%, for the year ended December 31, 2024 compared to the same period in 2023 primarily due to:

Removed

•an unfavorable impact of $1.7 billion to Other (charges) gains, net primarily in our Engineered Materials segment related to an impairment loss on goodwill of $1.5 billion and impairment losses on certain trade names, primarily Zytel® (see Note 9 - Goodwill and Intangible Assets, Net and Note 24 - Other (Charges) Gains, Net in the accompanying consolidated financial statements for further information);

Removed

•lower Net sales across our segments; and

Removed

•a gain of $515 million in our Engineered Materials segment recognized on the formation of the Nutrinova joint venture during the year ended December 31, 2023, which did not recur in the current year (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information);

Reworded

•lower raw material costsvolume in our Engineered Materials and Acetyl Chain segments.segments, primarily driven by weaker global economic conditions and decreased global demand; and

Added

•lower pricing in our Acetyl Chain segment, primarily due to an environment with greater supply than demand, as well as our Engineered Materials segment, primarily due to competitive market dynamics, and product mix;

Added

•a favorable currency impact, primarily resulting from a stronger euro relative to the U.S. dollar.

Removed

Non-operating pension and other postretirement employee expense decreased $49 million for the year ended December 31, 2024 compared to the same period in 2023 primarily due to a decrease in recognized actuarial loss of $29 million as a result of an increase in the weighted average discount rate used to determine benefit obligations from 4.5% to 4.8%, partially offset by lower than expected actual asset returns. See Note 12 - Benefit Obligations in the accompanying consolidated financial statements for further information.

Reworded

OurOperating effectiveloss incomeincreased tax$66 ratemillion, or 9%, for the year ended December 31, 2024 was (51)% compared to (67)% for the year ended 2023. The change in the effective income tax rate for the year ended December 31, 20242025 compared to the same period in 2023 was2024 primarily due to:

Added

•lower Net sales across our segments;

Added

•a favorable impact of $172 million to Other (charges) gains, net in our Engineered Materials segment, primarily due to a decrease in goodwill and certain trade names impairment losses and decreased severance costs (see Note 9 - Goodwill and Intangible Assets, Net and Note 24 - Other (Charges) Gains, Net in the accompanying consolidated financial statements for further information);

Added

•lower raw material costs in our Engineered Materials and Acetyl Chain segments;

Added

•lower spending of $195 million, primarily as a result of the realization of synergy and cost savings actions in our Engineered Materials and Other Activities segments during the year ended December 31, 2025; and

Added

•a decrease of accelerated depreciation expense of $56 million during the year ended December 31, 2025, primarily due to a decrease of $67 million in our Engineered Materials segment, related to the 2024 closures of our polymerization units in Uentrop, Germany and our facility in Mechelen, Belgium, partially offset by an increase in accelerated depreciation of $11 million in our Acetyl Chain segment related to the intended closure of our facility in Lanaken, Belgium (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information).

Added

Non-operating pension and other postretirement employee benefit income increased for the year ended December 31, 2025 compared to the same period in 2024 primarily due to:

Added

•a decrease in the actuarial loss of $82 million primarily due to higher than expected asset returns, partially offset by unfavorable plan experience and a decrease in the weighted average discount rate (see Note 12 - Benefit Obligations in the accompanying consolidated financial statements for further information).

Added

Our effective income tax rate for the year ended December 31, 2025 was 7.4% compared to (49.8)% for the year ended 2024. The change in the effective income tax rate for the year ended December 31, 2025 compared to the same period in 2024 was primarily due to:

Removed

•prior year impacts that did not recur in the current year, including the relocation of certain intangible assets to better align with the acquired M&M foreign operations, the realignment of our European headquarters and principal operations to Switzerland to achieve operational efficiencies, the release of valuation allowances on U.S. foreign tax credit carryforwards, and the excess of the U.S. GAAP gain over the tax gain from the formation of the Nutrinova joint venture; and

Reworded

•current year impacts of a non-deductible goodwill impairment loss andloss, recognition of a valuation allowance againston certainU.S. local country, non-U.S.foreign tax credit carryforwards due to reducedrevised forecasts of earningsforeign insourced future periodsincome and capitalexpenses gainsduring the carryforward period, the further integrated global principal operations and the relocation of certain intangible assets among wholly-owned foreign affiliates and the settlement of tax arisingexaminations fromwith anGerman internaltax integration-relatedauthorities; restructuring of our acquired China operations to optimize our debt profile.and

Added

•prior year impacts of a non-deductible goodwill impairment loss and recognition of a valuation allowance against certain local country, non-U.S. tax credit carryforwards due to reduced forecasts of earnings in future periods and capital gains tax arising from an internal integration-related restructuring of our acquired China operations to optimize our debt profile.

Added

•lower volume, primarily due to weaker global economic conditions; and

Removed

•lower volume, primarily driven by the formation of the Nutrinova joint venture (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information) and reduced demand for elastomers due to weaker automotive demand, partially offset by higher volume for certain products, principally for POM in Europe and Asia;

Reworded

•lower pricing for most of our products, primarily due to competitive market dynamics, and product mix, and decreased energy surchargesmix; and

Reworded

•ana unfavorablefavorable currency impact, primarily resulting from a weakerstronger JPY and CNYeuro relative to the U.S. dollar.

Reworded

Operating profitloss decreased for the year ended December 31, 20242025 compared to the same period in 20232024 primarily due to:

Reworded

•ana unfavorablefavorable impact of $1.7$172 billionmillion to Other (charges) gains, netnet, primarily related to ana impairmentdecrease loss onin goodwill ofand $1.5certain billiontrade andnames impairment losses onand certaindecreased tradeseverance names, primarily Zytel®costs (see Note 9 - Goodwill and Intangible Assets, Net and Note 24 - Other (Charges) Gains, Net in the accompanying consolidated financial statements for further information);

Removed

•a gain of $515 million recognized on the formation of the Nutrinova joint venture during the year ended December 31, 2023, which did not recur in the current year (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information); and

Removed

•lower Net sales;

Reworded

•lower raw materialsmaterial costs forand mostfavorable ofraw ourmaterials products.mix;

Removed

Equity in net earnings (loss) of affiliates increased for the year ended December 31, 2024 compared to the same period in 2023 primarily due to:

Removed

•an increase in earnings from our Mylar Specialty Films strategic affiliates of $61 million, primarily due to increased restructuring costs incurred in the year ended December 31, 2023, which did not recur in the current year.

Removed

Net sales decreased for the year ended December 31, 2024 compared to the same period in 2023 primarily due to:

Reworded

•lower pricing for mostspending of our$98 productsmillion, globally,primarily dueas toa anresult environmentof withthe greaterrealization supplyof thansynergy demandand cost savings actions during the year ended December 31, 20242025; and

Added

•a decrease of accelerated depreciation expense of $67 million for the year ended December 31, 2025, primarily related to the 2024 closures of our polymerization units in Uentrop, Germany and our facility in Mechelen, Belgium;

Added

•lower Net sales.

Removed

•higher volume for most of our products, primarily methanol, downstream derivative products, acid, and VAM.

Reworded

OperatingEquity profitin net earnings (loss) of affiliates decreased for the year ended December 31, 20242025 compared to the same period in 20232024 primarily due to:

Added

•a decrease in earnings from our Ibn Sina strategic affiliate, primarily due to lower methyl tertiary-butyl ether ("MTBE") volume arising from weaker economic conditions, as well as lower MTBE pricing and higher feedstock costs.

Added

Net sales decreased for the year ended December 31, 2025 compared to the same period in 2024 primarily due to:

Added

•lower pricing for most of our products globally, due to an environment with greater supply than demand; and

Added

•lower volume across the chain, primarily for acetate tow, due to decreased global demand;

Added

•a favorable currency impact, primarily resulting from a stronger euro relative to the U.S. dollar.

Added

Operating profit decreased for the year ended December 31, 2025 compared to the same period in 2024 primarily due to:

Added

•an increase of accelerated depreciation expense of $11 million for the year ended December 31, 2025, related to the intended closure of our facility in Lanaken, Belgium (see Note 4 - Acquisitions, Dispositions and Plant Closures in the accompanying consolidated financial statements for further information);

Removed

•higher spending of $40 million, primarily as a result of increased plant operating and maintenance expenses, including costs at our new acetic acid unit at Clear Lake, Texas, and plant turnaround costs related to our joint venture, Fairway Methanol LLC;

Reworded

•lower raw material and sourcing costs,costs primarilydriven forby carbonproductivity monoxide and methanol.initiatives.

Added

•lower spending of $97 million, primarily due to realization of synergy and cost savings actions during the year ended December 31, 2025.

Showing the first 60 of 147 changed paragraphs. The complete comparison will be part of Pro (coming soon). Meanwhile you can read the full text in the original filing.

What changed in the latest 10-Q

Comparing 10-Q filed 2026-08-05 (period ending 2026-06-30) with 10-Q filed 2026-05-06 (period ending 2026-03-31).

Risk Factors (10-Q Part II, Item 1A)

63new paragraphs
17removed paragraphs
42reworded paragraphs
6,608 → 8,329words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text topics: bankruptcy
“On July 31, 2026, we entered into a receivables purchase and financing agreement (the "European Receivables Purchase and Financing Agreement") and established an accounts receivable purchasing and financing facility among certain of our European subsidiaries, a wholly-owned, "bankruptcy remote" special purpose subsidiary (the "EU SPE") and certain global financial institutions. The European Receivables Purchase and Financing Agreement permits the EU SPE to either sell or borrow against certain receivables until July 31, 2028. …”
see in full comparison
Removed text topics: fine, china
“•a decrease in net borrowings on short-term debt of $238 million, primarily due to a decrease in net borrowings of $200 million under the November 2024 U.S. Term Loan Credit Facility, during three months ended March 31, 2025, which did not recur in the current year, and a decrease in net borrowings on our China Revolving Credit Facilities (defined below) and U.S. Revolving Credit Facility (defined below) of $49 million, as well as a decrease of net borrowings under various China working capital loans during the three months ended March 31, 2026;”
see in full comparison
Reworded topics: fine, china

Paragraph as it now reads, with added and removed wording marked:

•a decrease in repayments of long-term debt, primarily due to the March 2025 Tender Offers (defined below), of $1.1 billion, redemption of the 6.050% Senior Notes due March 15, 2025, partial repayment of $400 million of the March 2022 U.S. Term Loan Credit Facility (defined below), and redemption of the 1.250% Senior Notes due February 11, 2025, during the threesix months ended MarchJune 31,30, 2025, which did not recur in the current yearyear, partially offset by the redemption of the 4.777% Notes (defined below), and repayment of certain long-term China working capital loans during the six months ended June 30, 2026; and
see in full comparison
New text topics: restructuring
“•an unfavorable impact of $10 million to Other (charges) gains, net in our Acetyl Chain and Engineered Materials segments during the six months ended June 30, 2026, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment, and partially offset by lower restructuring costs related to the Company-wide business optimization projects in our Engineered Materials segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited …”
see in full comparison
New text topics: restructuring
“•accelerated depreciation expense of $22 million and an unfavorable impact of $20 million to Other (charges) gains, net, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information); and”
see in full comparison
New text topics: restructuring
“•accelerated depreciation expense of $40 million and an unfavorable impact of $26 million to Other (charges) gains, net, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);”
see in full comparison
Full comparison: every changed paragraph (122)

Green = added, red = removed. Unchanged paragraphs, 1 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

Net sales decreasedincreased $52$220 million, or 2%,9%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Removed

•lower volume in our Acetyl Chain segment, primarily driven by decreased global demand; and

Reworded

•lowerhigher pricing,pricing primarily driven byin our Acetyl Chain segmentsegment, primarily due to an environment with greaterregional supply than demand,dislocation, as well as ourhigher Engineeredraw Materialsmaterials segmentand duesourcing to competitive market dynamicscosts;

Added

•higher pricing in our Engineered Materials segment, primarily due to pricing actions implemented during the three months ended June 30, 2026, as well as a more favorable product mix; and

Reworded

•a favorable currency impact from our Engineered Materials and Acetyl Chain segments, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar.dollar;

Removed

Operating profit increased $49 million, or 30%, for the three months ended March 31, 2026 compared to the same period in 2025, primarily due to:

Reworded

•alower gainvolume ofin $50our millionEngineered recognizedMaterials onsegment, primarily due to the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);.

Removed

•lower spending of $47 million, primarily in our Engineered Materials segment as a result of the positive impact from our planned inventory build as well as the realization of cost savings and productivity actions, partially offset by higher spending in our Other Activities segment, primarily related to higher merger and acquisition and incentive compensation costs incurred during the three months ended March 31, 2026; and

Removed

•lower raw material costs in our Engineered Materials segment;

Removed

•lower Net sales in our Acetyl Chain segment.

Reworded

EquityOperating in net earnings (loss) of affiliatesprofit increased $13$45 million, or 59%,19%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher Net sales across all of our segments; and

Added

•lower raw materials costs in our Engineered Materials segment, primarily driven by productivity initiatives and sourcing changes;

Added

•higher accelerated depreciation expense of $65 million during the three months ended June 30, 2026 in our Engineered Materials and Acetyl Chain segments, primarily related to the announced closure of our facilities in Sakra, Singapore and Ulsan, South Korea, and optimization of the North American nylon 6,6 polymerization units in our Engineered Materials segment, and the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);

Added

•higher raw materials and sourcing costs in our Acetyl Chain segment, primarily for ethylene and methanol;

Added

•higher spending of $49 million in our Engineered Material segment, primarily as a result of higher inventory and turnaround costs at our Frankfurt polyoxymethylene ("POM") unit during the three months ended June 30, 2026;

Added

•higher spending of $48 million in our Acetyl Chain and Other Activities segments during the three months ended June 30, 2026, primarily as a result of increased plant operating and maintenance expenses and higher logistics costs in our Acetyl Chain segment, as well as higher incentive compensation and merger and acquisition costs incurred in Other Activities; and

Added

•an unfavorable impact of $20 million to Other (charges) gains, net in our Acetyl Chain segment, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information).

Added

Equity in net earnings (loss) of affiliates decreased $18 million, or 62%, for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•a decrease in earnings from our Mylar Specialty Films strategic affiliate, primarily due to restructuring activities.

Removed

•an increase in earnings from our Ibn Sina strategic affiliate, primarily as a result of lower methyl tertiary-butyl ether ("MTBE") volumes arising from a plant turnaround during the three months ended March 31, 2025, which did not recur in the current year.

Reworded

Our effective income tax rate for the three months ended MarchJune 31,30, 2026 was 40%8% compared to (15058)% for the same period in 2025. The change in the effective income tax rate for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025 was primarily due to increasedfavorable earningstax items recorded in the currentprior-year year,period asthat welldid asnot changesrecur in uncertain2026, including net deferred tax benefits related to priorthe yearrelocation of certain intangible assets among wholly-owned foreign affiliates as part of the continued integration of global principal operations and a tax benefit associated with the settlement of German tax examinations infor variousthe foreign2008 jurisdictionsthrough and differences in functional currency for2012 tax purposesyears. The higher rate also reflected unfavorable functional-currency tax impacts in certain jurisdictions,jurisdictions during the current period. These effects were partially offset by favorable changes in the geographic mix of earnings in the current year.year and by reductions in valuation allowances on foreign tax credit carryforwards resulting from revised forecasts of foreign-sourced income and expenses during the applicable carryforward period. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

Added

Net sales increased $168 million, or 3%, for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher pricing in our Acetyl Chain segment, primarily due to regional supply dislocation, as well as higher raw materials and sourcing costs;

Added

•higher pricing in our Engineered Materials segment, primarily due to pricing actions implemented during the three months ended June 30, 2026, as well as a more favorable product mix; and

Added

•a favorable currency impact from our Engineered Materials and Acetyl Chain segments, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar;

Added

•lower volume in our Engineered Materials and Acetyl Chain segments, primarily due to the completed sale of the Micromax® business in our Engineered Materials segment (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information), and decreased global demand in our Acetyl Chain segment.

Added

Operating profit increased $94 million, or 24%, for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher Net sales across all of our segments;

Added

•a gain of $50 million in our Engineered Materials segment, recognized on the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information); and

Added

•lower raw materials costs in our Engineered Materials segment, primarily driven by productivity initiatives and sourcing changes;

Added

•higher accelerated depreciation expense of $85 million in our Engineered Materials and Acetyl Chain segments during the six months ended June 30, 2026, primarily related to the announced closure of our facilities in Sakra, Singapore and Ulsan, South Korea, and optimization of the North American nylon 6,6 polymerization units in our Engineered Materials segment, and the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);

Added

•higher spending of $73 million in our Other Activities and Acetyl Chain segments during the six months ended June 30, 2026, primarily related to higher incentive compensation and merger and acquisition costs in Other Activities segment, and increased plant operating and maintenance expenses and higher logistics costs in our Acetyl Chain segment;

Added

•higher raw materials costs in our Acetyl Chain segment, primarily for ethylene and methanol; and

Added

•an unfavorable impact of $10 million to Other (charges) gains, net in our Acetyl Chain and Engineered Materials segments during the six months ended June 30, 2026, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment, and partially offset by lower restructuring costs related to the Company-wide business optimization projects in our Engineered Materials segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information).

Added

Our effective income tax rate for the six months ended June 30, 2026 was 20% compared to (54)% for the same period in 2025. The higher effective income tax rate was primarily due to favorable tax items recorded in the prior-year period that did not recur in 2026, including net deferred tax benefits related to the relocation of certain intangible assets among wholly-owned foreign affiliates as part of the continued integration of global principal operations and a tax benefit associated with the settlement of German tax examinations for the 2008 through 2012 tax years. The higher rate also reflected unfavorable functional-currency tax impacts in certain jurisdictions during the current period. These effects were partially offset by favorable changes in the geographic mix of earnings in the current year and by reductions in valuation allowances on foreign tax credit carryforwards resulting from revised forecasts of foreign-sourced income and expenses during the applicable carryforward period. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

Reworded

Net sales increased for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Removed

•a favorable currency impact, primarily resulting from a stronger euro relative to the U.S. dollar;

Reworded

•lowerhigher pricing for most of our products, primarily due to competitivepricing marketactions dynamics.implemented during the three months ended June 30, 2026, as well as a more favorable product mix; and

Added

•a favorable currency impact, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar;

Added

largely offset by:

Removed

Operating profit increased for the three months ended March 31, 2026 compared to the same period in 2025, primarily due to:

Removed

•lower spending of $56 million, primarily as a result of the positive impact from our planned inventory build as well as the realization of cost savings and productivity actions during the three months ended March 31, 2026;

Reworded

•alower gainvolume, ofprimarily $50due million recognized onto the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information); and.

Removed

•lower raw materials costs, primarily driven by productivity initiatives.

Reworded

EquityOperating inprofit net earnings (loss) of affiliates increaseddecreased for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher spending of $49 million, primarily as a result of higher inventory and turnaround costs at our Frankfurt POM unit during the three months ended June 30, 2026; and

Added

•accelerated depreciation expense of $43 million, primarily related to the announced closure of our facilities in Sakra, Singapore and Ulsan, South Korea, and optimization of the North American nylon 6,6 polymerization units during the three months ended June 30, 2026;

Added

•higher Net sales; and

Added

•lower raw materials costs, primarily driven by productivity initiatives and sourcing changes.

Added

Equity in net earnings (loss) of affiliates decreased for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•a decrease in earnings from our Mylar Specialty Films strategic affiliate, primarily due to restructuring activities.

Added

Net sales increased for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•a favorable currency impact, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar; and

Added

•higher pricing for most of our products, primarily due to pricing actions implemented during the three months ended June 30, 2026, as well as a more favorable product mix;

Added

largely offset by:

Added

•lower volume, primarily due to the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information).

Added

Operating profit increased for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher Net sales;

Added

•a gain of $50 million recognized on the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);

Showing the first 60 of 122 changed paragraphs. The complete comparison will be part of Pro (coming soon). Meanwhile you can read the full text in the original filing.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

63new paragraphs
17removed paragraphs
42reworded paragraphs
7,074 → 8,795words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

New text topics: bankruptcy
“On July 31, 2026, we entered into a receivables purchase and financing agreement (the "European Receivables Purchase and Financing Agreement") and established an accounts receivable purchasing and financing facility among certain of our European subsidiaries, a wholly-owned, "bankruptcy remote" special purpose subsidiary (the "EU SPE") and certain global financial institutions. The European Receivables Purchase and Financing Agreement permits the EU SPE to either sell or borrow against certain receivables until July 31, 2028. …”
see in full comparison
Removed text topics: fine, china
“•a decrease in net borrowings on short-term debt of $238 million, primarily due to a decrease in net borrowings of $200 million under the November 2024 U.S. Term Loan Credit Facility, during three months ended March 31, 2025, which did not recur in the current year, and a decrease in net borrowings on our China Revolving Credit Facilities (defined below) and U.S. Revolving Credit Facility (defined below) of $49 million, as well as a decrease of net borrowings under various China working capital loans during the three months ended March 31, 2026;”
see in full comparison
Reworded topics: fine, china

Paragraph as it now reads, with added and removed wording marked:

•a decrease in repayments of long-term debt, primarily due to the March 2025 Tender Offers (defined below), of $1.1 billion, redemption of the 6.050% Senior Notes due March 15, 2025, partial repayment of $400 million of the March 2022 U.S. Term Loan Credit Facility (defined below), and redemption of the 1.250% Senior Notes due February 11, 2025, during the threesix months ended MarchJune 31,30, 2025, which did not recur in the current yearyear, partially offset by the redemption of the 4.777% Notes (defined below), and repayment of certain long-term China working capital loans during the six months ended June 30, 2026; and
see in full comparison
New text topics: restructuring
“•an unfavorable impact of $10 million to Other (charges) gains, net in our Acetyl Chain and Engineered Materials segments during the six months ended June 30, 2026, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment, and partially offset by lower restructuring costs related to the Company-wide business optimization projects in our Engineered Materials segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited …”
see in full comparison
New text topics: restructuring
“•accelerated depreciation expense of $22 million and an unfavorable impact of $20 million to Other (charges) gains, net, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information); and”
see in full comparison
New text topics: restructuring
“•accelerated depreciation expense of $40 million and an unfavorable impact of $26 million to Other (charges) gains, net, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);”
see in full comparison
Full comparison: every changed paragraph (122)

Green = added, red = removed. Unchanged paragraphs, 1 paragraphs where only numbers/dates changed, and tables are not shown. Read the complete text in the original filing.

Reworded

Net sales decreasedincreased $52$220 million, or 2%,9%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Removed

•lower volume in our Acetyl Chain segment, primarily driven by decreased global demand; and

Reworded

•lowerhigher pricing,pricing primarily driven byin our Acetyl Chain segmentsegment, primarily due to an environment with greaterregional supply than demand,dislocation, as well as ourhigher Engineeredraw Materialsmaterials segmentand duesourcing to competitive market dynamicscosts;

Added

•higher pricing in our Engineered Materials segment, primarily due to pricing actions implemented during the three months ended June 30, 2026, as well as a more favorable product mix; and

Reworded

•a favorable currency impact from our Engineered Materials and Acetyl Chain segments, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar.dollar;

Removed

Operating profit increased $49 million, or 30%, for the three months ended March 31, 2026 compared to the same period in 2025, primarily due to:

Reworded

•alower gainvolume ofin $50our millionEngineered recognizedMaterials onsegment, primarily due to the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);.

Removed

•lower spending of $47 million, primarily in our Engineered Materials segment as a result of the positive impact from our planned inventory build as well as the realization of cost savings and productivity actions, partially offset by higher spending in our Other Activities segment, primarily related to higher merger and acquisition and incentive compensation costs incurred during the three months ended March 31, 2026; and

Removed

•lower raw material costs in our Engineered Materials segment;

Removed

•lower Net sales in our Acetyl Chain segment.

Reworded

EquityOperating in net earnings (loss) of affiliatesprofit increased $13$45 million, or 59%,19%, for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher Net sales across all of our segments; and

Added

•lower raw materials costs in our Engineered Materials segment, primarily driven by productivity initiatives and sourcing changes;

Added

•higher accelerated depreciation expense of $65 million during the three months ended June 30, 2026 in our Engineered Materials and Acetyl Chain segments, primarily related to the announced closure of our facilities in Sakra, Singapore and Ulsan, South Korea, and optimization of the North American nylon 6,6 polymerization units in our Engineered Materials segment, and the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);

Added

•higher raw materials and sourcing costs in our Acetyl Chain segment, primarily for ethylene and methanol;

Added

•higher spending of $49 million in our Engineered Material segment, primarily as a result of higher inventory and turnaround costs at our Frankfurt polyoxymethylene ("POM") unit during the three months ended June 30, 2026;

Added

•higher spending of $48 million in our Acetyl Chain and Other Activities segments during the three months ended June 30, 2026, primarily as a result of increased plant operating and maintenance expenses and higher logistics costs in our Acetyl Chain segment, as well as higher incentive compensation and merger and acquisition costs incurred in Other Activities; and

Added

•an unfavorable impact of $20 million to Other (charges) gains, net in our Acetyl Chain segment, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information).

Added

Equity in net earnings (loss) of affiliates decreased $18 million, or 62%, for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•a decrease in earnings from our Mylar Specialty Films strategic affiliate, primarily due to restructuring activities.

Removed

•an increase in earnings from our Ibn Sina strategic affiliate, primarily as a result of lower methyl tertiary-butyl ether ("MTBE") volumes arising from a plant turnaround during the three months ended March 31, 2025, which did not recur in the current year.

Reworded

Our effective income tax rate for the three months ended MarchJune 31,30, 2026 was 40%8% compared to (15058)% for the same period in 2025. The change in the effective income tax rate for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025 was primarily due to increasedfavorable earningstax items recorded in the currentprior-year year,period asthat welldid asnot changesrecur in uncertain2026, including net deferred tax benefits related to priorthe yearrelocation of certain intangible assets among wholly-owned foreign affiliates as part of the continued integration of global principal operations and a tax benefit associated with the settlement of German tax examinations infor variousthe foreign2008 jurisdictionsthrough and differences in functional currency for2012 tax purposesyears. The higher rate also reflected unfavorable functional-currency tax impacts in certain jurisdictions,jurisdictions during the current period. These effects were partially offset by favorable changes in the geographic mix of earnings in the current year.year and by reductions in valuation allowances on foreign tax credit carryforwards resulting from revised forecasts of foreign-sourced income and expenses during the applicable carryforward period. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

Added

Net sales increased $168 million, or 3%, for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher pricing in our Acetyl Chain segment, primarily due to regional supply dislocation, as well as higher raw materials and sourcing costs;

Added

•higher pricing in our Engineered Materials segment, primarily due to pricing actions implemented during the three months ended June 30, 2026, as well as a more favorable product mix; and

Added

•a favorable currency impact from our Engineered Materials and Acetyl Chain segments, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar;

Added

•lower volume in our Engineered Materials and Acetyl Chain segments, primarily due to the completed sale of the Micromax® business in our Engineered Materials segment (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information), and decreased global demand in our Acetyl Chain segment.

Added

Operating profit increased $94 million, or 24%, for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher Net sales across all of our segments;

Added

•a gain of $50 million in our Engineered Materials segment, recognized on the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information); and

Added

•lower raw materials costs in our Engineered Materials segment, primarily driven by productivity initiatives and sourcing changes;

Added

•higher accelerated depreciation expense of $85 million in our Engineered Materials and Acetyl Chain segments during the six months ended June 30, 2026, primarily related to the announced closure of our facilities in Sakra, Singapore and Ulsan, South Korea, and optimization of the North American nylon 6,6 polymerization units in our Engineered Materials segment, and the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information);

Added

•higher spending of $73 million in our Other Activities and Acetyl Chain segments during the six months ended June 30, 2026, primarily related to higher incentive compensation and merger and acquisition costs in Other Activities segment, and increased plant operating and maintenance expenses and higher logistics costs in our Acetyl Chain segment;

Added

•higher raw materials costs in our Acetyl Chain segment, primarily for ethylene and methanol; and

Added

•an unfavorable impact of $10 million to Other (charges) gains, net in our Acetyl Chain and Engineered Materials segments during the six months ended June 30, 2026, primarily related to restructuring costs associated with the previously announced closure of our facility in Lanaken, Belgium in our Acetyl Chain segment, and partially offset by lower restructuring costs related to the Company-wide business optimization projects in our Engineered Materials segment (see Note 3 - Acquisitions, Dispositions and Plant Closures and Note 18 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information).

Added

Our effective income tax rate for the six months ended June 30, 2026 was 20% compared to (54)% for the same period in 2025. The higher effective income tax rate was primarily due to favorable tax items recorded in the prior-year period that did not recur in 2026, including net deferred tax benefits related to the relocation of certain intangible assets among wholly-owned foreign affiliates as part of the continued integration of global principal operations and a tax benefit associated with the settlement of German tax examinations for the 2008 through 2012 tax years. The higher rate also reflected unfavorable functional-currency tax impacts in certain jurisdictions during the current period. These effects were partially offset by favorable changes in the geographic mix of earnings in the current year and by reductions in valuation allowances on foreign tax credit carryforwards resulting from revised forecasts of foreign-sourced income and expenses during the applicable carryforward period. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

Reworded

Net sales increased for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Removed

•a favorable currency impact, primarily resulting from a stronger euro relative to the U.S. dollar;

Reworded

•lowerhigher pricing for most of our products, primarily due to competitivepricing marketactions dynamics.implemented during the three months ended June 30, 2026, as well as a more favorable product mix; and

Added

•a favorable currency impact, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar;

Added

largely offset by:

Removed

Operating profit increased for the three months ended March 31, 2026 compared to the same period in 2025, primarily due to:

Removed

•lower spending of $56 million, primarily as a result of the positive impact from our planned inventory build as well as the realization of cost savings and productivity actions during the three months ended March 31, 2026;

Reworded

•alower gainvolume, ofprimarily $50due million recognized onto the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information); and.

Removed

•lower raw materials costs, primarily driven by productivity initiatives.

Reworded

EquityOperating inprofit net earnings (loss) of affiliates increaseddecreased for the three months ended MarchJune 31,30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher spending of $49 million, primarily as a result of higher inventory and turnaround costs at our Frankfurt POM unit during the three months ended June 30, 2026; and

Added

•accelerated depreciation expense of $43 million, primarily related to the announced closure of our facilities in Sakra, Singapore and Ulsan, South Korea, and optimization of the North American nylon 6,6 polymerization units during the three months ended June 30, 2026;

Added

•higher Net sales; and

Added

•lower raw materials costs, primarily driven by productivity initiatives and sourcing changes.

Added

Equity in net earnings (loss) of affiliates decreased for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•a decrease in earnings from our Mylar Specialty Films strategic affiliate, primarily due to restructuring activities.

Added

Net sales increased for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•a favorable currency impact, primarily resulting from a stronger euro and Chinese yuan relative to the U.S. dollar; and

Added

•higher pricing for most of our products, primarily due to pricing actions implemented during the three months ended June 30, 2026, as well as a more favorable product mix;

Added

largely offset by:

Added

•lower volume, primarily due to the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information).

Added

Operating profit increased for the six months ended June 30, 2026 compared to the same period in 2025, primarily due to:

Added

•higher Net sales;

Added

•a gain of $50 million recognized on the completed sale of the Micromax® business (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);

Showing the first 60 of 122 changed paragraphs. The complete comparison will be part of Pro (coming soon). Meanwhile you can read the full text in the original filing.

CE insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 3 Form 4 filings (3 insiders, 2 trade dates, 5,053 shares, about $230.1K) and open-market sales in 0 filings. Net open-market shares: 5,053 (purchases minus sales); net value about $230.1K.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

Trade dateInsiderTransactionSharesPriceValueOwned afterFiling
2026-08-14Kyrish Chuck
SVP & CFO
Open-market purchase 800$45.51 $36.4K29,114 SEC
2026-08-14Kyrish Chuck
SVP & CFO
Open-market purchase 1,400$45.53 $63.7K28,214 SEC
2026-08-14Kyrish Chuck
SVP & CFO
Open-market purchase 100$45.51 $4.6K28,314 SEC
2026-08-11Duffie Ashley B
SVP & GC
Open-market purchase 600$45.60 $27.4K31,925 SEC
2026-08-11Murray Mark Christopher
SVP - Acetyls
Open-market purchase 2,153$45.52 $98.0K30,432 SEC
2026-08-10Galante Edward G
Director
Grant/award 1,930— —27,983 SEC
2026-05-11Chinn Bruce E.
Director
Grant/award 2,975— —7,261 SEC
2026-05-11Noonan Anne P
Director
Grant/award 2,975— —2,975 SEC
2026-05-11Koenig Michael
Director
Grant/award 2,975— —8,320 SEC
2026-05-11Moorthy Ganesh
Director
Grant/award 2,975— —8,990 SEC
2026-05-11Kissire Deborah J.
Director
Grant/award 2,975— —4,075 SEC
2026-05-11Rucker Kim K.w.
Director
Grant/award 2,975— —3,031 SEC
2026-05-11Hill Kathryn
Director
Grant/award 2,975— —19,783 SEC
2026-05-11Kuehn Christopher J
Director
Grant/award 2,975— —2,975 SEC
2026-05-11Galante Edward G
Director
Grant/award 4,676— —26,053 SEC
2026-05-09Koenig Michael
Director
Shares withheld for tax 1,013$57.51 $58.3K5,345 SEC
2026-05-09Kissire Deborah J.
Director
Disposition to issuer 3,376— —1,100 SEC
2026-05-09Rucker Kim K.w.
Director
Disposition to issuer 3,376— —56 SEC
2026-05-09Kuehn Christopher J
Director
Disposition to issuer 3,376— —0 SEC

Well-known investors holding CE (13F)

InvestorQuarterSharesReported value% of their 13FChange vs prior quarter
Dodge & Cox COM2026-06-3015,282,234$703.0M0.37%No change
Millennium Management (Israel Englander) COM2026-06-301,635,133$75.2M0.05%Added 5%
Citadel Advisors (Ken Griffin) COM2026-06-301,221,610$56.2M0.03%Added 206%
Point72 Asset Management (Steve Cohen) COM2026-06-30617,266$28.4M0.04%Added 16%
Two Sigma Investments COM2026-06-30436,476$20.1M0.02%Reduced 9%
Gotham Asset Management (Joel Greenblatt) COM2026-06-30319,236$14.7M0.03%Added 52%
Bridgewater Associates COM2026-06-30117,410$5.4M0.02%Added 2%
AQR Capital Management (Cliff Asness) COM2026-06-3081,483$3.7M0.0%Reduced 30%
Renaissance Technologies COM2026-06-3028,500$1.9M—Sold out
D. E. Shaw & Co. COM2026-06-3039,905$1.8M0.0%Reduced 78%

13F reports are filed up to 45 days after quarter end and show long U.S. equity positions only; options positions are omitted here.

Coming soon: email alerts when CE files, watchlists and downloadable comparisons.